Unison Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$260K Hold
18,000
– – 0.02% 168
2026
Q2
$384K Hold
18,000
– – 0.03% 169
2026
Q1
$314K Hold
18,000
– – 0.02% 174
2025
Q4
$353K Hold
18,000
– – 0.03% 173
2025
Q3
$496K Hold
18,000
– – 0.05% 158
2025
Q2
$550K Hold
18,000
– – 0.06% 147
2025
Q1
$485K Hold
18,000
– – 0.06% 151
2024
Q4
$646K Hold
18,000
– – 0.08% 133
2024
Q3
$683K Buy
+18,000
New +$740K 0.08% 135

Other funds holding USNA

Unison Advisors's USNA Position: Q3 2026 in Review

Unison Advisors held its Usana Health Sciences (USNA) position steady in Q3 2026 at 18,000 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #168.

Unison Advisors first reported a position in USNA in Q3 2024 and has held it in 9 quarters since. The position peaked at $683K in Q3 2024. 125 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Unison Advisors held 18,000 shares of Usana Health Sciences worth $260K as of Q3 2026.
  • Unison Advisors left its Usana Health Sciences share count unchanged in Q3 2026.
  • Usana Health Sciences made up 0.02% of Unison Advisors's portfolio in Q3 2026, its #168 holding.
  • Unison Advisors first reported a position in Usana Health Sciences in Q3 2024 and has held it in 9 quarters since.
  • Unison Advisors's Usana Health Sciences position peaked at $683K in Q3 2024.
  • 125 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Unison Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.